Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2024年10月10日
	新闻
	The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer ... Nature The occurrence of multiple primary lung cancer (MPLC) has witnessed a significant surge in recent years within the Chinese population. 标记为不相关
	ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers AACR Journals ERK1/2 inhibition in ASCL1-expressing lung tumor cells revealed downregulation of ERK1/2 pathway suppressors SPRY4, SPRED1, DUSP6, and the ... 标记为不相关
	AHN explores use of promising new blood-based test to enhance lung cancer detection The Latrobe Bulletin The American Cancer Society recommends yearly screening for lung cancer with a low-dose CT scan for people 50 to 80 years old who have a 20 pack-year ... 标记为不相关
	Significant Savings Associated With CyPath Lung Test Medical Product Outsourcing Study finds adding CyPath Lung to the standard of care for private-payer patients with a positive lung cancer screening result could save $6460 ... 标记为不相关
	Durvalumab Shows Manageable Safety Profile in LS-SCLC - Cancer Network Cancer Network A manageable safety profile was observed with durvalumab (Imfinzi) consolidation treatment in patients with limited-stage small cell lung cancer ... 标记为不相关
	specific cancers - Statistics Explained - European Commission European Commission - European Union ... cancer: trachea, bronchus and lung cancer (hereafter referred to simply as lung cancer); colorectal cancer; breast cancer; and prostate cancer. 标记为不相关
	Roche CDx Test Receives CE Marking for Use in Gastric Cancer Patients | 360Dx 360Dx ... cancer who may be eligible for treatment with Astellas ... Roche Receives Additional FDA Approval for CDx that Supports Lung Cancer Treatment. 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈